COVID-19 antivirals must not affect HIV drug supply

Bibliographic Details
Main Authors:	Barber, M. (Author), Cepuch, C. (Author), Sarpatwari, A. (Author)
Format:	Article
Language:	English
Published:	Elsevier Ltd 2022
Subjects:	Antiviral Agents antivirus agent coronavirus disease 2019 COVID-19 high income country HIV Infections human Human immunodeficiency virus Human immunodeficiency virus infection Humans hydroxychloroquine lopinavir nonhuman Note pandemic ritonavir
Online Access:	View Fulltext in Publisher


LEADER	00987nam a2200337Ia 4500
001	10-1016-S2352-3018-21-00321-0
008	220420s2022 CNT 000 0 und d
020			\|a 23523018 (ISSN)
245	1	0	\|a COVID-19 antivirals must not affect HIV drug supply
260		0	\|b Elsevier Ltd \|c 2022
856			\|z View Fulltext in Publisher \|u https://doi.org/10.1016/S2352-3018(21)00321-0
650	0	4	\|a Antiviral Agents
650	0	4	\|a antivirus agent
650	0	4	\|a coronavirus disease 2019
650	0	4	\|a COVID-19
650	0	4	\|a high income country
650	0	4	\|a HIV Infections
650	0	4	\|a human
650	0	4	\|a Human immunodeficiency virus
650	0	4	\|a Human immunodeficiency virus infection
650	0	4	\|a Humans
650	0	4	\|a hydroxychloroquine
650	0	4	\|a lopinavir
650	0	4	\|a nonhuman
650	0	4	\|a Note
650	0	4	\|a pandemic
650	0	4	\|a ritonavir
700	1	0	\|a Barber, M. \|e author
700	1	0	\|a Cepuch, C. \|e author
700	1	0	\|a Sarpatwari, A. \|e author
773			\|t The Lancet HIV

Similar Items